MoonLake Immunotherapeutics is a clinical-stage biotechnology company developing SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody licensed from MHKDG, for inflammatory skin and joint diseases. SLK is being evaluated in hidradenitis suppurativa (HS), psoriatic arthritis (PsA), axial spondyloarthritis (axSpA), palmoplantar pustulosis (PPP), and psoriasis. The company is preparing a BLA submission for HS in the second half of 2026, with a potential U.S. commercial launch in the second half of 2027.
Q2 FY2026 — expected 2026-09-12
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-25 | 2025-12-31 | 0001821586-26-000002 | EDGAR | 87K words |
| 2025-02-26 | 2024-12-31 | 0001821586-25-000006 | EDGAR | 83K words |
| 2024-02-29 | 2023-12-31 | 0001821586-24-000008 | EDGAR | 74K words |
| 2023-03-20 | 2022-12-31 | 0001821586-23-000007 | EDGAR | 89K words |
| 2022-02-17 | 2021-12-31 | 0001213900-22-008253 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001213900-21-019007 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-10 | 2026-06-30 | 0001821586-26-000010 | EDGAR | 24K words |
| 2025-11-05 | 2025-09-30 | 0001821586-25-000022 | EDGAR | 27K words |
| 2025-08-05 | 2025-06-30 | 0001821586-25-000018 | EDGAR | 26K words |
| 2025-05-12 | 2025-03-31 | 0001821586-25-000011 | EDGAR | 27K words |
| 2024-11-07 | 2024-09-30 | 0001821586-24-000029 | EDGAR | 22K words |
| 2024-08-07 | 2024-06-30 | 0001821586-24-000025 | EDGAR | 23K words |
| 2024-05-07 | 2024-03-31 | 0001821586-24-000020 | EDGAR | 22K words |
| 2023-11-14 | 2023-09-30 | 0001821586-23-000022 | EDGAR | 27K words |
| 2023-08-10 | 2023-06-30 | 0001821586-23-000015 | EDGAR | 26K words |
| 2023-05-11 | 2023-03-31 | 0001821586-23-000012 | EDGAR | 23K words |
| 2022-11-14 | 2022-09-30 | 0001821586-22-000009 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001821586-22-000006 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-10 | 0001213900-26-086939 | EDGAR | 6K words |
| 2026-07-15 | 0001213900-26-078031 | EDGAR | 1K words |
| 2026-02-23 | 0001213900-26-018967 | EDGAR | 4K words |
| 2026-01-08 | 0001213900-26-002344 | EDGAR | 4K words |
| 2025-11-05 | 0001213900-25-106723 | EDGAR | 24K words |
| 2025-11-05 | 0001821586-25-000021 | EDGAR | 5K words |
| 2025-09-29 | 0001213900-25-092614 | EDGAR | 6K words |
| 2025-08-05 | 0001821586-25-000016 | EDGAR | 5K words |
| 2025-06-06 | 0001213900-25-052140 | EDGAR | 1K words |
| 2025-05-12 | 0001821586-25-000009 | EDGAR | 5K words |
92 total filings indexed. 64 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001821586 |
| Ticker | MLTX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | E9 |
| Website | https://www.moonlaketx.com |
| Listed | 2022-04-06 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/MLTX (~200 tokens, structured JSON with cryptographic provenance)